Home › Chemotherapy › Chemotherapy Drug Classes — and What They Mean for You

Chemotherapy drug classes

Chemotherapy Drug Classes and What They Mean for You

Medically reviewed by Dr. Naresh Gundu, Medical Oncologist, MBBS (Chalmeda Anand Rao Institute of Medical Sciences, Karimnagar) · DNB Internal Medicine (Sir Gangaram Hospital, New Delhi) · DM Medical Oncology (AIIMS) · Last reviewed September 2026

The name on your prescription may mean nothing to you right now. Knowing which class it belongs to is the fastest way to understand what to expect and what to watch for.

Prescription-only medicine.

Chemotherapy is a prescription-only treatment given only under the supervision of a specialist oncologist in a hospital or approved cancer care centre. Nothing in this article can be used to start, change, or stop any chemotherapy drug. It is not suitable for everyone — see who this is not for below.

Talk to an oncologist

Leave your details and a member of the oncology team will call you back to answer questions about your treatment plan.

No charge for the call, and no obligation to book anything.

412Chemotherapy pages, written and reviewed

17Oncologists on the panel

10Centres across Hyderabad

41Locations across two states

In short

Chemotherapy drugs are grouped into classes based on how they attack cancer cells. Alkylating agents damage DNA directly; antimetabolites block the materials cells need to divide; taxanes stop cells from physically splitting. The class on your prescription predicts which side effects to expect and which symptoms to report urgently to your team.

In detail

What are the main chemotherapy drug classes?

Chemotherapy works by targeting cells that divide rapidly. Different classes do this in different ways — attacking DNA directly, blocking the raw materials cells need, or jamming the machinery that physically splits a cell in two.

Alkylating agents, including cyclophosphamide, cisplatin, carboplatin, and oxaliplatin, attach directly to DNA and cross-link its strands. This stops the cell from making a copy of itself.

Antimetabolites, including methotrexate, 5-fluorouracil, gemcitabine, and capecitabine, mimic the building blocks cells use to make new DNA. When a dividing cell tries to use them, the copying process stalls and fails.

Anthracyclines, including doxorubicin and epirubicin, block the enzymes that unwind and re-wind DNA during copying. This jams the process at a different point from alkylating agents.

Taxanes, including paclitaxel and docetaxel, and vinca alkaloids, including vincristine and vinorelbine, both disrupt the spindle — the scaffolding that physically pulls a dividing cell in two. They work on opposite ends of the same structure.

Topoisomerase inhibitors, including irinotecan and etoposide, block a separate set of enzymes that manage the coiling of DNA while it is being copied.

In detail

How does the drug class predict which side effects you may get?

Each class tends to damage certain tissues because of where in the cell it acts. This is why oncologists can broadly anticipate the side-effect pattern before treatment begins.

Platinum-based alkylating agents — cisplatin, carboplatin, oxaliplatin — are particularly associated with peripheral neuropathy, the numbness or tingling in hands and feet. NCCN guidance identifies this as a common effect of platinum agents. It can persist after treatment ends.

Antimetabolites that act on the gut lining, such as 5-fluorouracil and capecitabine, commonly cause mouth sores and diarrhoea. Capecitabine is also associated with hand-foot syndrome — redness and soreness of the palms and soles.

Anthracyclines carry a cumulative risk to the heart. ESMO and ASCO guidance recognises a dose-related risk of cardiac effects with this class, which is why the total dose across all cycles is tracked carefully.

Taxanes frequently cause peripheral neuropathy alongside hair loss and joint and muscle aching. Reporting nerve symptoms early — when you first notice numbness or tingling — gives your team the most options for managing them.

Most regimens combine drugs from different classes deliberately. NCCN guidance states that combination regimens attack the cancer by multiple mechanisms and reduce the chance of resistance developing.

Eligibility

Who chemotherapy may not be suitable for

Eligibility for any chemotherapy drug is decided by an oncologist based on individual biology, test results, and current health. No general list overrides that clinical assessment.

Significant kidney or liver impairment: Many drugs in these classes are processed by the kidneys or liver. Reduced organ function may prevent safe use of specific agents.
Pregnancy: Most chemotherapy drugs carry a risk of harm to the developing foetus, particularly in the first trimester. Use in pregnancy is considered only in rare circumstances.
Very poor general fitness: Patients unable to carry out basic self-care (ECOG performance status 3 or 4) may not tolerate chemotherapy safely.
Active uncontrolled infection: Chemotherapy suppresses the immune system. Starting a cycle during an active infection increases the risk of serious harm.
Blood counts not yet recovered: If counts from a previous cycle remain too low, the next cycle is delayed until safe thresholds are reached.

Want to talk this through with an oncologist?

Leave your number and an oncology coordinator will call you back at a time that suits you.

Step by step

What should you do when you see an unfamiliar drug name on your prescription?

Write down the full generic name

Ask for it in writing if it was only said aloud. The generic name — not a brand name — is what your team and any other doctor you see will recognise and use.

Ask which class it belongs to

Your oncologist or chemotherapy nurse can tell you immediately. The class is the fastest way to understand the mechanism and the likely side-effect pattern.

Ask which side effects that class commonly causes

Ask specifically: which ones are common, which ones are rare but serious, and which ones are expected to settle after treatment ends.

Ask which symptoms must be reported the same day

Every drug class has a short list of symptoms that cannot wait for your next appointment. Ask your team to name them for your specific regimen before you leave.

Write it down before you leave the consultation

Memory of clinical conversations is poor under stress. A short written note of the drug name, class, and key symptoms to watch gives you something reliable to refer to at home.

Worth knowing

Did you know?

Most chemotherapy regimens use drugs from more than one class at the same time. This is intentional, not incidental.

Combining classes that attack different points in the cell cycle makes it harder for cancer cells to develop resistance — and is the basis of regimens such as CHOP, FOLFOX, and AC-T that you may see named on your treatment plan.

Source: NCCN Clinical Practice Guidelines in Oncology: Principles of Chemotherapy

Still have a question about your treatment? Tell us what is on your chart and an oncologist will explain what it means for you, what to expect and what your schedule is likely to look like.

Talk to an oncologist 1800 202 8726

Common questions

Frequently asked questions

Why am I being given more than one chemotherapy drug?

Combining drugs from different classes is standard practice rather than a sign that one drug alone is not enough. Each class attacks a different part of the cell cycle, so cancer cells that survive one mechanism are vulnerable to another. NCCN and ASCO guidance for most solid tumours specifies combination regimens rather than single agents. The specific combination you are on was chosen based on your cancer type, stage, and fitness.

Why do some chemotherapy drugs cause nerve damage and others do not?

Peripheral neuropathy — numbness, tingling, or pain in the hands and feet — is associated specifically with platinum agents and taxanes, because these drugs accumulate in or damage peripheral nerve fibres in a way that other classes do not. Antimetabolites and anthracyclines work through mechanisms that do not primarily affect peripheral nerves. This is why the same cancer can be treated two different ways with very different side-effect patterns.

What is the difference between the generic name and the brand name of a chemotherapy drug?

The generic name is the scientific name of the molecule — cyclophosphamide, paclitaxel, doxorubicin — and it is the same regardless of who manufactures it. The brand name is a commercial name applied to one version of it, and it can vary between countries or suppliers. Your oncology team will always use the generic name because it is unambiguous. If you are told a brand name, ask for the generic alongside it so you know exactly what you are receiving.

If two people have the same cancer, why might they be given drugs from different classes?

The cancer type is one input among several. Your oncologist also considers your stage, biomarker results, organ function, fitness, and any previous treatment you have had. Someone who has already received an anthracycline may not receive another because of the cumulative heart dose. Someone with reduced kidney function may not safely receive certain platinum agents. The same diagnosis often has more than one guideline-recommended option, and the choice is made for the individual.

Does the chemotherapy class change if the first treatment stops working?

Yes, typically. Second-line chemotherapy usually involves switching to a different class or a different combination, because the cancer cells that survived the first regimen are by definition less sensitive to it. This is one reason the class distinction matters across your whole treatment journey, not just at the start. Your oncologist will explain the second-line options and what distinguishes them from what you received before.

Can I take chemotherapy tablets at home or does it always have to be given by infusion?

Some chemotherapy drugs are available as oral tablets taken at home — capecitabine and methotrexate are examples from the antimetabolite class. Others are given by infusion in a day care unit. Whether you receive an oral or intravenous form depends on the drug chosen, the regimen, and your individual situation — it is not a choice between convenience and effectiveness. Oral chemotherapy is still prescription-only and still requires regular monitoring by your oncology team. Never adjust the dose or timing without speaking to them first.

Who would be treating you

The medical oncologists on the CION panel

Chemotherapy is prescribed, dosed and supervised by a medical oncologist. These are the six on the CION panel.

Dr. Naresh Gundu

Medical Oncologist

MBBS · DNB Internal Medicine (Sir Gangaram, New Delhi) · DM Medical Oncology (AIIMS)

Call Book appointment

Dr. C. Raghavendra Reddy

Medical Oncologist

MBBS (Gold Medal) · DNB · DM (Medical Oncology, Gold Medal) · Kukatpally

Call Book appointment

Dr. Bharati Devi Gorantla

Medical Oncologist

MBBS · MD · DM (Adyar, Chennai) · ECMO · MRCP SCE (UK)

Call Book appointment

Dr. Owais Mohammed

Medical Oncologist

Call Book appointment

Dr. T. Raghavender Reddy

Medical Oncologist

MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · L.B. Nagar

Call Book appointment

Dr. N. Kiranmayee

Medical Oncologist

Call Book appointment

Which oncologist you see depends on the centre nearest you and on what your treatment involves. Tell us where you are and we will point you to the closest.

Talk it through

Reading about a medicine is not the same as being told what to expect

This page explains what the medicine does in general. What it cannot tell you is how your own regimen was chosen, what your schedule looks like, or which of these effects apply to you — that needs your reports and a conversation.

Free first consultation Second opinion on an existing plan 10 centres across Hyderabad

Speak to an oncologist

Share your details and the team will call you back to arrange a consultation or a second opinion.

Bring your reports if you have them. If you do not, come anyway.

list of links to other editorial pages, which base contract s2.1 permits explicitly. It contains no form, no phone number and no CTA button, so it does not turn this page into an advertisement. Generated by scripts/hub_update.py --include-out. -->

Full index